Among the TB vaccines, AS01 used in the M72 vaccine is a monophosphoryl lipid A (MPL, TLR-4 agonist)-based adjuvant and liposomal formulation combined with a saponin [6]. This evidence concerns the gene TLR4 and tuberculosis.